| Drug Name |
Treprostinil |
| Drug ID |
BADD_D02268 |
| Description |
Treprostinil is a synthetic analogue of prostacyclin, used to treat pulmonary hypertension. |
| Indications and Usage |
For use as a continuous subcutaneous infusion or intravenous infusion (for those not able to tolerate a subcutaneous infusion) for the treatment of pulmonary arterial hypertension in patients with NYHA Class II-IV symptoms to diminish symptoms associated with exercise. |
| Marketing Status |
Prescription |
| ATC Code |
B01AC21 |
| DrugBank ID |
DB00374
|
| KEGG ID |
D06213
|
| MeSH ID |
C427248
|
| PubChem ID |
6918140
|
| TTD Drug ID |
D01WUA
|
| NDC Product Code |
0703-0696; 62332-516; 68245-0008; 0703-0666; 0703-0686; 0781-3427; 58159-041; 0781-3420; 66302-120; 0703-0676; 62332-515; 66302-110; 42023-206; 42023-208; 42023-207; 62332-517; 11014-0094; 81861-0029; 62332-514; 66302-102; 54893-0024; 66302-300; 66302-302; 14501-0015; 66302-206; 0781-3425; 66302-350; 66302-105; 66302-101; 42023-209; 0781-3430; 66302-310; 66302-325 |
| Synonyms |
treprostinil | ((1R,2R,3AS,9AS)-2-hydroxy-1-((3S)-3-hydroxyoctyl)-2,3,3A,4,9,9A-hexahydro-1H-cylopent(b)naphthalen-5-yl)oxy)acetate | treprostinil sodium | trepostinil sodium | Orenitram | UT-15 | UT-15C | Remodulin | treprostinil diolamine | treprostinil diolamin | treprostinil diethanolamine |
